Your browser doesn't support javascript.
loading
Management of Adult Patients With Drug Reaction With Eosinophilia and Systemic Symptoms: A Delphi-Based International Consensus.
Brüggen, Marie-Charlotte; Walsh, Sarah; Ameri, M Milad; Anasiewicz, Natalie; Maverakis, Emanual; French, Lars E; Ingen-Housz-Oro, Saskia; Abe, Richiiro; Ardern-Jones, Michael; Assier, Haudrey; Barbaud, Annick; Bensaid, Benoit; Bernal, William; Bernier, Claire; Brassard, Alain; Brezinová, Eva; Cabañas, Rosario; Cardones, Adela; Chu, Chia-Yu; Chua, Ser-Ling; Descamps, Vincent; Didona, Biagio; Divito, Sherrie Jill; Dodiuk-Gad, Roni; Elman, Scott; Gaspar, Krisztian; Mortz, Charlotte G; Hama, Natsumi; Lee, Haur Yueh; Horváth, Barbara; Jörg, Lukas; Kaffenberger, Benjamin H; Kucinskiene, Vesta; Lebrun-Vignes, Bénédicte; Lehloenya, Rannakoe J; Meyersburg, Damian; Micheletti, Robert; Milpied, Brigitte; Miyagawa, Fumi; Mostaghimi, Arash; Nägeli, Mirjam; Naldi, Luigi; Oppel, Eva; Phillips, Elizabeth J; Pirani, Tasneem; Ranki, Annamari; Mälkönen, Tarja; Rosenbach, Misha; Salavastru, Carmen; Staumont-Salle, Delphine.
Afiliação
  • Brüggen MC; Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland.
  • Walsh S; Faculty of Medicine, University of Zurich, Zurich, Switzerland.
  • Ameri MM; Christine Kühne-Center for Allergy Research and Education (CK-CARE), Davos, Switzerland.
  • Anasiewicz N; ToxiTEN group, European Reference Network for Rare Skin Diseases (ERN-Skin), Paris, France.
  • Maverakis E; ToxiTEN group, European Reference Network for Rare Skin Diseases (ERN-Skin), Paris, France.
  • French LE; Department of Dermatology, King's College Hospital, London, England, United Kingdom.
  • Ingen-Housz-Oro S; Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland.
  • Abe R; Christine Kühne-Center for Allergy Research and Education (CK-CARE), Davos, Switzerland.
  • Ardern-Jones M; Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland.
  • Assier H; Department of Dermatology, University of California, Davis, Sacramento, California.
  • Barbaud A; ToxiTEN group, European Reference Network for Rare Skin Diseases (ERN-Skin), Paris, France.
  • Bensaid B; Department of Dermatology and Allergy, University Hospital, Ludwig-Maximilians-University (LMU) Munich, Munich, Germany.
  • Bernal W; Dr Phillip Frost Department of Dermatology and Cutaneous Surgery, Miller School of Medicine, University of Miami, Miami, Florida.
  • Bernier C; ToxiTEN group, European Reference Network for Rare Skin Diseases (ERN-Skin), Paris, France.
  • Brassard A; Department of Dermatology, Henri Mondor University Hospital, University of Paris-Est Créteil, Créteil, France.
  • Brezinová E; Toxic Bullous Dermatoses TOXIBUL Reference Center, Filière FIMARAD, AP-HP, Henri Mondor Hospital, Créteil, France.
  • Cabañas R; Univ Paris Est Créteil EpiDermE, Créteil, France.
  • Chu CY; Division of Dermatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
  • Chua SL; Department of Dermatology, Clinical Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, England, United Kingdom.
  • Descamps V; Department of Dermatology, Henri Mondor University Hospital, University of Paris-Est Créteil, Créteil, France.
  • Didona B; Sorbonne Université, INSERM, Institut Pierre Louis d'Epidemiologie et de Sante Publique, AP-HP Sorbonne Universite, Tenon Hospital, Department of Dermatology and Allergology, Paris, France.
  • Divito SJ; Department of Dermatology, Lyon Natecia Hospital, Lyon, France.
  • Dodiuk-Gad R; Liver Intensive Therapy Unit, King's Critical Care, King's College Hospital, London, England, United Kingdom.
  • Elman S; Department of Dermatology, University Hospital Nantes, Nantes, France.
  • Gaspar K; Department of Dermatology, University of California, Davis, Sacramento, California.
  • Mortz CG; ToxiTEN group, European Reference Network for Rare Skin Diseases (ERN-Skin), Paris, France.
  • Hama N; Department of Dermatovenereology, St Anne's Faculty Hospital, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
  • Lee HY; Department of Allergy, La Paz University Hospital, IdiPAZ, Madrid, Spain.
  • Horváth B; PIELenRed Consortium, Madrid, Spain.
  • Jörg L; Center for Biomedical Research Network on Rare Diseases (CIBERER U754), Madrid, Spain.
  • Kaffenberger BH; Department of Dermatology, University of Kansas, Kansas City.
  • Kucinskiene V; Department of Dermatology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.
  • Lebrun-Vignes B; ToxiTEN group, European Reference Network for Rare Skin Diseases (ERN-Skin), Paris, France.
  • Lehloenya RJ; Department of Dermatology, University of California, San Francisco.
  • Meyersburg D; Department of Dermatology, Bichat-Claude Bernard Hospital, Paris Diderot University, Paris, France.
  • Micheletti R; ToxiTEN group, European Reference Network for Rare Skin Diseases (ERN-Skin), Paris, France.
  • Milpied B; Center of Rare Diseases IDI-IRCCS, Rome, Italy.
  • Miyagawa F; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Mostaghimi A; Department of Dermatology, Emek Medical Center, Afula, Israel.
  • Nägeli M; Division of Dermatology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
  • Naldi L; Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
  • Oppel E; Department of Dermatology, Miller School of Medicine, University of Miami, Miami, Florida.
  • Phillips EJ; Department of Dermatology, University of Debrecen, Debrecen, Hungary.
  • Pirani T; Department of Dermatology and Allergy Center, Odense University Hospital, University of Southern Denmark, Odense, Denmark.
  • Ranki A; Division of Dermatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
  • Mälkönen T; Department of Dermatology, Singapore General Hospital, Singapore, Singapore.
  • Rosenbach M; Center for Blistering Diseases, Department of Dermatology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • Salavastru C; Division of Allergology and Clinical Immunology, Department of Pneumology and Allergology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Staumont-Salle D; Department of Dermatology, The Ohio State University, Columbus, Ohio.
JAMA Dermatol ; 160(1): 37-44, 2024 Jan 01.
Article em En | MEDLINE | ID: mdl-37966824
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Eosinofilia / Síndrome de Hipersensibilidade a Medicamentos Limite: Adult / Humans Idioma: En Revista: JAMA Dermatol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Suíça
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Eosinofilia / Síndrome de Hipersensibilidade a Medicamentos Limite: Adult / Humans Idioma: En Revista: JAMA Dermatol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Suíça